You are here

  • Home
  • Archive
  • Volume 21, Issue 6
  • Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody

Article metrics

Article menu
Download PDFPDF
Uterine Cancer
Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2024

AbstractFullPdf
Jan 20191400
Feb 20198800
Mar 20193000
Apr 20193902
May 20192100
Jun 20191801
Jul 20191000
Aug 20191200
Sep 20191000
Oct 20192300
Nov 20191200
Dec 20194600
Jan 20201400
Feb 20201000
Mar 20201100
Apr 2020600
May 20201700
Jun 20201100
Jul 20201800
Aug 20202400
Sep 20205000
Oct 20201000
Nov 20201100
Dec 20202200
Jan 20212600
Feb 20211000
Apr 2021400
Jul 2021100
Oct 20211400
Nov 20211300
Dec 20211001
Jan 20221400
Feb 2022800
Mar 20221900
Apr 20221600
May 20223600
Jun 20223500
Jul 20223500
Aug 20224201
Sep 20226200
Oct 20224100
Nov 20222200
Dec 20222701
Jan 2023800
Feb 20237300
Mar 2023600
Apr 2023800
May 20231301
Jun 2023601
Jul 2023900
Aug 20231000
Sep 20237800
Oct 202313600
Nov 202329200
Dec 20232200
Jan 20242800
Feb 20241000
Mar 20242600
Apr 20242000
Total170708